Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07520383 · ClinicalTrials.gov registry record · Phase 1
Nanopulse Laser Therapy
A Phase 1 study, sponsored by The University of Texas Medical Branch, Galveston.
- Not yet
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT07520383 is a Phase 1 study that has not yet begun recruiting, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 30 participants.
The verdict
NCT07520383, a Phase 1 study, has not yet begun recruiting, sponsored by The University of Texas Medical Branch, Galveston.
- NOT YET RECRUITING
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and effectiveness of a novel noninvasive therapy, Nanopulse Laser Therapy (NPLT), to improve recovery following traumatic brain injury (TBI).
Interventions
- DEVICE Nano-Pulsed Laser Therapy (NPLT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-05 |
| Est. Completion | 2027-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07520383
The ClinicalTrials.gov registry entry for NCT07520383 describes a study currently listed as not yet recruiting, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Medical Branch, Galveston, which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nano-Pulsed Laser Therapy (NPLT) is the first listed.
NCT07520383 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07520383 about?
NCT07520383 is a clinical study titled "Nanopulse Laser Therapy". The purpose of this study is to evaluate the safety and effectiveness of a novel noninvasive therapy, Nanopulse Laser Therapy (NPLT), to improve recovery following traumatic brain injury (TBI).
What is the current status of trial NCT07520383?
This trial is currently not yet recruiting. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2026-05. Estimated completion is 2027-05.
What interventions are being tested in trial NCT07520383?
The interventions under investigation include: Nano-Pulsed Laser Therapy (NPLT) (DEVICE).
Who is sponsoring clinical trial NCT07520383?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.